API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
79
PharmaCompass offers a list of Carisoprodol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carisoprodol manufacturer or Carisoprodol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carisoprodol manufacturer or Carisoprodol supplier.
PharmaCompass also assists you with knowing the Carisoprodol API Price utilized in the formulation of products. Carisoprodol API Price is not always fixed or binding as the Carisoprodol Price is obtained through a variety of data sources. The Carisoprodol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Carisoprodol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carisoprodol, including repackagers and relabelers. The FDA regulates Carisoprodol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carisoprodol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carisoprodol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Carisoprodol supplier is an individual or a company that provides Carisoprodol active pharmaceutical ingredient (API) or Carisoprodol finished formulations upon request. The Carisoprodol suppliers may include Carisoprodol API manufacturers, exporters, distributors and traders.
click here to find a list of Carisoprodol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Carisoprodol DMF (Drug Master File) is a document detailing the whole manufacturing process of Carisoprodol active pharmaceutical ingredient (API) in detail. Different forms of Carisoprodol DMFs exist exist since differing nations have different regulations, such as Carisoprodol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Carisoprodol DMF submitted to regulatory agencies in the US is known as a USDMF. Carisoprodol USDMF includes data on Carisoprodol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carisoprodol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Carisoprodol suppliers with USDMF on PharmaCompass.
A Carisoprodol CEP of the European Pharmacopoeia monograph is often referred to as a Carisoprodol Certificate of Suitability (COS). The purpose of a Carisoprodol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Carisoprodol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Carisoprodol to their clients by showing that a Carisoprodol CEP has been issued for it. The manufacturer submits a Carisoprodol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Carisoprodol CEP holder for the record. Additionally, the data presented in the Carisoprodol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Carisoprodol DMF.
A Carisoprodol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Carisoprodol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Carisoprodol suppliers with CEP (COS) on PharmaCompass.
A Carisoprodol written confirmation (Carisoprodol WC) is an official document issued by a regulatory agency to a Carisoprodol manufacturer, verifying that the manufacturing facility of a Carisoprodol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Carisoprodol APIs or Carisoprodol finished pharmaceutical products to another nation, regulatory agencies frequently require a Carisoprodol WC (written confirmation) as part of the regulatory process.
click here to find a list of Carisoprodol suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Carisoprodol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Carisoprodol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Carisoprodol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Carisoprodol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Carisoprodol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Carisoprodol suppliers with NDC on PharmaCompass.
Carisoprodol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Carisoprodol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Carisoprodol GMP manufacturer or Carisoprodol GMP API supplier for your needs.
A Carisoprodol CoA (Certificate of Analysis) is a formal document that attests to Carisoprodol's compliance with Carisoprodol specifications and serves as a tool for batch-level quality control.
Carisoprodol CoA mostly includes findings from lab analyses of a specific batch. For each Carisoprodol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Carisoprodol may be tested according to a variety of international standards, such as European Pharmacopoeia (Carisoprodol EP), Carisoprodol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carisoprodol USP).